MOLINA ARTURO MD

Chief Medical Officer

MOLINA ARTURO MD has filed 5 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Mar 27, 2026.

On the most recent filing, MOLINA ARTURO MD is listed as Chief Medical Officer at Protagonist Therapeutics, Inc. Inside the rolling window, MOLINA ARTURO MD reported no open-market purchases and 6 open-market sales totaling $4.5M in PTGX. The largest disclosed transaction in the window is a sale of 15,000 PTGX shares on Mar 26, 2026, worth $1.6M.

Companies traded

Other insiders at PTGX

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$4.5M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
PTGXSale$1.6MMar 27SEC ↗
PTGXSale$1.1MJan 27SEC ↗
PTGXSale$411KJan 27SEC ↗
PTGXSale$410KJan 27SEC ↗
PTGXSale$785KJan 21SEC ↗
PTGXSale$230KNov 19SEC ↗
Showing 1–6 of 6
1 / 1

Frequently asked questions

How many SEC Form 4 filings has MOLINA ARTURO MD made?

MOLINA ARTURO MD has filed 5 SEC Form 4 filings (10 transaction rows) across 1 company since 2025.

Which companies does MOLINA ARTURO MD trade?

MOLINA ARTURO MD has filed SEC Form 4 disclosures for 1 company, including PTGX.

When was MOLINA ARTURO MD's most recent SEC Form 4 filing?

MOLINA ARTURO MD's most recent SEC Form 4 filing on Tracefour is dated Mar 27, 2026.

What is MOLINA ARTURO MD's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, MOLINA ARTURO MD is listed as Chief Medical Officer.

What is MOLINA ARTURO MD's total buy and sell value in the current window?

Inside the rolling retention window, MOLINA ARTURO MD bought $0 and sold $4.5M based on SEC Form 4 filings.

What was MOLINA ARTURO MD's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 15,000 PTGX shares on 2026-03-26, worth $1.6M, per SEC Form 4 filings.